Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$907M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$644M |
| 4 |
NVIDIA
NVDA
|
+$440M |
| 5 |
CRH
CRH
|
+$429M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$689M |
| 2 |
Home Depot
HD
|
+$377M |
| 3 |
Cigna
CI
|
+$322M |
| 4 |
Valero Energy
VLO
|
+$250M |
| 5 |
Amphenol
APH
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.35% |
| 2 | Technology | 9.23% |
| 3 | Healthcare | 7.6% |
| 4 | Financials | 5.15% |
| 5 | Consumer Discretionary | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Cullinan Oncology
CGEM
$1.4B
| $2.17M | ﹤0.01% |
239,725
+50,652
| +27% | +$528K |
|
|
GRTS
3402
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $2.17M | ﹤0.01% |
1,261,120
-34,317
| -3% | -$60.9K |
|
|
GOLD
3403
Gold.com Inc
GOLD
$1.32B
| $2.17M | ﹤0.01% |
73,917
-94,404
| -56% | -$3.41M |
|
3404
PUT
InMode
INMD
$855M
| $2.17M | ﹤0.01% |
71,100
+19,300
| +37% | +$758K |
|
3405
CALL
Corteva
CTVA
$56B
| $2.16M | ﹤0.01% |
42,300
-111,800
| -73% | -$5.92M |
|
3406
Supernus Pharmaceuticals
SUPN
$2.54B
| $2.16M | ﹤0.01% |
78,205
-55,270
| -41% | -$1.68M |
|
|
UCTT
3407
Ultra Clean Holdings
UCTT
$3.15B
| $2.16M | ﹤0.01% |
72,645
+41,132
| +131% | +$1.39M |
|
3408
VanEck BDC Income ETF
BIZD
$1.7B
| $2.15M | ﹤0.01% |
134,393
-86,446
| -39% | -$1.35M |
|
3409
Ocular Therapeutix
OCUL
$2.28B
| $2.15M | ﹤0.01% |
685,740
-1,711,100
| -71% | -$7M |
|
3410
PUT
BioMarin Pharmaceuticals
BMRN
$12.5B
| $2.15M | ﹤0.01% |
+24,300
| New | +$2.16M |
|
3411
ALPS Clean Energy ETF
ACES
$110M
| $2.15M | ﹤0.01% |
+58,751
| New | +$2.53M |
|
|
CEPU
3412
Central Puerto
CEPU
$2.01B
| $2.15M | ﹤0.01% |
369,083
+159,178
| +76% | +$1.05M |
|
3413
Sylvamo
SLVM
$1.45B
| $2.15M | ﹤0.01% |
48,865
+36,482
| +295% | +$1.57M |
|
3414
PUT
Roblox
RBLX
$27.5B
| $2.14M | ﹤0.01% |
74,000
+67,400
| +1,021% | +$2.24M |
|
3415
CALL
Boston Properties
BXP
$11.1B
| $2.14M | ﹤0.01% |
36,000
+500
| +1% | +$32K |
|
3416
CALL
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$133M
| $2.14M | ﹤0.01% |
22,950
-2,050
| -8% | -$193K |
|
|
SVC
3417
Service Properties Trust
SVC
$1.02B
| $2.14M | ﹤0.01% |
55,620
+15,287
| +38% | +$636K |
|
|
LCW
3418
DELISTED
Learn CW Investment Corporation Class A Ordinary Shares
LCW
| $2.14M | ﹤0.01% |
200,600
| – | – |
|
|
CBAY
3419
DELISTED
Cymabay Therapeutics
CBAY
| $2.14M | ﹤0.01% |
143,404
-1,300,590
| -90% | -$17.2M |
|
3420
Associated Banc-Corp
ASB
$5.84B
| $2.13M | ﹤0.01% |
124,687
+110,993
| +811% | +$1.95M |
|
3421
CALL
American Electric Power
AEP
$66.6B
| $2.13M | ﹤0.01% |
28,300
-1,600
| -5% | -$130K |
|
3422
PUT
Monolithic Power Systems
MPWR
$61.7B
| $2.13M | ﹤0.01% |
4,600
-1,300
| -22% | -$665K |
|
3423
Magna International
MGA
$17.6B
| $2.12M | ﹤0.01% |
39,533
-99,714
| -72% | -$5.81M |
|
3424
CALL
Avis
CAR
$4.88B
| $2.12M | ﹤0.01% |
11,800
+10,300
| +687% | +$2.23M |
|
3425
Vanguard Health Care ETF
VHT
$19.3B
| $2.12M | ﹤0.01% |
9,007
+5,118
| +132% | +$1.25M |
|
Similar funds
Israel Englander's Q3 2023 Portfolio in Review
As of Q3 2023, Israel Englander held 6,895 positions worth $198B, down 2.3% from $203B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Israel Englander deployed $6.14B of net new capital in Q3 2023, opening 836 new positions and adding to 2,326 existing holdings. Its largest new stake was Mobileye: 2,953,164 shares worth $123M.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 56% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $689M trimmed.
- Israel Englander's largest Q3 2023 buy was Mobileye: 2,953,164 shares worth $123M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.7B increase.
- Israel Englander's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $689M.
- Israel Englander fully exited Blackstone in Q3 2023, selling an estimated $178M.
- Israel Englander's ten largest holdings make up 21% of its $198B portfolio in Q3 2023.
- Israel Englander opened 836 new positions and closed 834 in Q3 2023.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $198B.
Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.